Major histocompatibility complex class I restricted cytotoxic T cells specific for natural melanoma peptides recognize unidentified shared melanoma antigen(s)

Maria Adele Imro, Simona Manici, Vincenzo Russo, Giuseppe Consogno, Matteo Bellone, Claudio Rugarli, Catia Traversari, Maria Pia Protti

Research output: Contribution to journalArticle

Abstract

CTLs were generated in vitro from two healthy donors and one melanoma patient by stimulation of CD8+ T cells with autologous dendritic cells pulsed with natural melanoma peptides (NMPs), obtained by acid treatment of HLA-matched melanoma cells. CTLs showed MHC class I-restricted melanoma- specific cytolytic activity. Importantly, CTLs from the patient, induced with NMPs obtained from an allogeneic HLA-A-matched melanoma, killed the autologous tumor. COS-7 cells cotransfected with the cDNA of 13 melanoma antigens and the HLA-A1-restricting allele did not induce cytokines release from NMP-specific CTLs, suggesting that they recognize unidentified shared melanoma antigens and that they may be valuable for identification of new tumor antigens. These results strongly support the use of autologous and/or allogeneic NMP-pulsed dendritic cells as cancer vaccines in patients whose neoplasms do not express or have lost expression of known tumor antigens.

Original languageEnglish
Pages (from-to)2287-2291
Number of pages5
JournalCancer Research
Volume59
Issue number10
Publication statusPublished - May 15 1999

Fingerprint

Melanoma-Specific Antigens
Major Histocompatibility Complex
Melanoma
T-Lymphocytes
Peptides
Neoplasm Antigens
Dendritic Cells
HLA-A1 Antigen
Cancer Vaccines
HLA-A Antigens
COS Cells
Neoplasms
Complementary DNA
Alleles
Tissue Donors
Cytokines
Acids

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Major histocompatibility complex class I restricted cytotoxic T cells specific for natural melanoma peptides recognize unidentified shared melanoma antigen(s). / Imro, Maria Adele; Manici, Simona; Russo, Vincenzo; Consogno, Giuseppe; Bellone, Matteo; Rugarli, Claudio; Traversari, Catia; Protti, Maria Pia.

In: Cancer Research, Vol. 59, No. 10, 15.05.1999, p. 2287-2291.

Research output: Contribution to journalArticle

@article{f6671f5aa99343dca0b87e0e34795512,
title = "Major histocompatibility complex class I restricted cytotoxic T cells specific for natural melanoma peptides recognize unidentified shared melanoma antigen(s)",
abstract = "CTLs were generated in vitro from two healthy donors and one melanoma patient by stimulation of CD8+ T cells with autologous dendritic cells pulsed with natural melanoma peptides (NMPs), obtained by acid treatment of HLA-matched melanoma cells. CTLs showed MHC class I-restricted melanoma- specific cytolytic activity. Importantly, CTLs from the patient, induced with NMPs obtained from an allogeneic HLA-A-matched melanoma, killed the autologous tumor. COS-7 cells cotransfected with the cDNA of 13 melanoma antigens and the HLA-A1-restricting allele did not induce cytokines release from NMP-specific CTLs, suggesting that they recognize unidentified shared melanoma antigens and that they may be valuable for identification of new tumor antigens. These results strongly support the use of autologous and/or allogeneic NMP-pulsed dendritic cells as cancer vaccines in patients whose neoplasms do not express or have lost expression of known tumor antigens.",
author = "Imro, {Maria Adele} and Simona Manici and Vincenzo Russo and Giuseppe Consogno and Matteo Bellone and Claudio Rugarli and Catia Traversari and Protti, {Maria Pia}",
year = "1999",
month = "5",
day = "15",
language = "English",
volume = "59",
pages = "2287--2291",
journal = "Journal of Cancer Research",
issn = "0008-5472",
publisher = "American Association for Cancer Research Inc.",
number = "10",

}

TY - JOUR

T1 - Major histocompatibility complex class I restricted cytotoxic T cells specific for natural melanoma peptides recognize unidentified shared melanoma antigen(s)

AU - Imro, Maria Adele

AU - Manici, Simona

AU - Russo, Vincenzo

AU - Consogno, Giuseppe

AU - Bellone, Matteo

AU - Rugarli, Claudio

AU - Traversari, Catia

AU - Protti, Maria Pia

PY - 1999/5/15

Y1 - 1999/5/15

N2 - CTLs were generated in vitro from two healthy donors and one melanoma patient by stimulation of CD8+ T cells with autologous dendritic cells pulsed with natural melanoma peptides (NMPs), obtained by acid treatment of HLA-matched melanoma cells. CTLs showed MHC class I-restricted melanoma- specific cytolytic activity. Importantly, CTLs from the patient, induced with NMPs obtained from an allogeneic HLA-A-matched melanoma, killed the autologous tumor. COS-7 cells cotransfected with the cDNA of 13 melanoma antigens and the HLA-A1-restricting allele did not induce cytokines release from NMP-specific CTLs, suggesting that they recognize unidentified shared melanoma antigens and that they may be valuable for identification of new tumor antigens. These results strongly support the use of autologous and/or allogeneic NMP-pulsed dendritic cells as cancer vaccines in patients whose neoplasms do not express or have lost expression of known tumor antigens.

AB - CTLs were generated in vitro from two healthy donors and one melanoma patient by stimulation of CD8+ T cells with autologous dendritic cells pulsed with natural melanoma peptides (NMPs), obtained by acid treatment of HLA-matched melanoma cells. CTLs showed MHC class I-restricted melanoma- specific cytolytic activity. Importantly, CTLs from the patient, induced with NMPs obtained from an allogeneic HLA-A-matched melanoma, killed the autologous tumor. COS-7 cells cotransfected with the cDNA of 13 melanoma antigens and the HLA-A1-restricting allele did not induce cytokines release from NMP-specific CTLs, suggesting that they recognize unidentified shared melanoma antigens and that they may be valuable for identification of new tumor antigens. These results strongly support the use of autologous and/or allogeneic NMP-pulsed dendritic cells as cancer vaccines in patients whose neoplasms do not express or have lost expression of known tumor antigens.

UR - http://www.scopus.com/inward/record.url?scp=0033563082&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033563082&partnerID=8YFLogxK

M3 - Article

C2 - 10344730

AN - SCOPUS:0033563082

VL - 59

SP - 2287

EP - 2291

JO - Journal of Cancer Research

JF - Journal of Cancer Research

SN - 0008-5472

IS - 10

ER -